Raymond James Reiterates Outperform Rating on Harmony Biosciences (HRMY), Sees Continued Growth and Multiple Opportunities for Additional Upside
Tweet Send to a Friend
Raymond James analyst Danielle Brill reiterated an Outperform rating on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY), following the company's most ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
